longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Cogent Biosciences(COGT.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

De-Extinct Dire Wolves Ready To Breed; Bioscience Company Pushes Forward Multiple Projects

ZeroHedge·05/09/2026 23:42
US
MBX
+3.42%
US
DTIL
+4.06%
US
COGT
+5.36%
ZeroHedge·05/09/2026 23:42
US
MBX
+3.42%
US
DTIL
+4.06%
US
COGT
+5.36%

Cogent Biosciences | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·05/05/2026 20:10
US
COGT
+5.36%
Earnings Watch·05/05/2026 20:10
US
COGT
+5.36%

A Look At Cogent Biosciences (COGT) Valuation After New KRAS And ErbB2 Data At AACR 2026

Simplywall·04/27/2026 14:07
US
COGT
+5.36%
Simplywall·04/27/2026 14:07
US
COGT
+5.36%

Southwest Airlines, Colliers International, and more stocks see action from activist investors

MSN·04/11/2026 05:51
US
BBIO
+3.36%
US
LUV
+6.29%
US
COGT
+5.36%
MSN·04/11/2026 05:51
US
BBIO
+3.36%
US
LUV
+6.29%
US
COGT
+5.36%

Cogent Biosciences (COGT) Is Up 6.1% After FDA NDA Filing For Bezuclastinib In GIST

Simplywall·04/10/2026 18:02
US
COGT
+5.36%
Simplywall·04/10/2026 18:02
US
COGT
+5.36%

The $10B Company Behind The Dire Wolf Is Now Bringing Back Mammoths

Forbes·04/09/2026 23:30
US
LABU
+11.76%
US
ARKG
+5.05%
US
BBH
+0.96%
Forbes·04/09/2026 23:30
US
LABU
+11.76%
US
ARKG
+5.05%
US
BBH
+0.96%
© 2026 Longbridge|Disclaimer

Event Tracking

May6
Cogent Biosciences released FY2026 Q1 earnings on May 5 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5999 (forecast USD -0.5409)
03:00
May5
Cogent Biosciences Inc Reports Q1 Loss, Preparing for New Drug Launch
12:07
Apr21
Cogent Biosciences Achieves Expected Goals in Late-Stage GIST Treatment Trial
12:07
Apr17
Cogent Biosciences to Present Preclinical Updates on Oncology Programs at AACR Annual Meeting
12:03
Apr1
Cogent Biosciences' GIST drug application submission leads to 6% stock price drop
14:37
Fairmount Funds Management Reduces Holdings in Cogent Biosciences
01:31

Schedules & Filings

Schedules
Filings
May5
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -97.35 M, EPS -0.5999

Feb17
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -102.49 M, EPS -0.6829

Nov3
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -80.93 M, EPS -0.588

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
OPTH
6.080
+2,485.03%
+5.845
HCWB
2.430
+129.25%
+1.370
SLXN
0.5298
+96.95%
+0.261
VIDA
4.150
+81.22%
+1.860
GCL
0.7445
+72.46%
+0.313
PHGE
0.5969
+59.60%
+0.223
MTVA
2.890
+53.72%
+1.010
MWC
7.150
+51.48%
+2.430
PETZ
1.150
+41.98%
+0.340
MLGO
5.360
+39.95%
+1.530
View More